| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |